Back to Archived Journals » Core Evidence » Volume 14

Enasidenib in the treatment of relapsed/refractory acute myeloid leukemia: an evidence-based review of its place in therapy

Total article views   HTML views PDF downloads Totals
16,669 Dovepress* 9,505+ 1,543 11,048
PubMed Central* 7,164 745 7,909
Totals 16,669 2,288 18,957
*Since 26 April 2019
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar